Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model

Cardiovasc Res. 2011 Mar 1;89(4):852-61. doi: 10.1093/cvr/cvq380. Epub 2010 Nov 30.

Abstract

Aims: Pre-treatment with dietary ω3 polyunsaturated fatty acids (ω3-PUFA) has been reported to reduce the incidence of new-onset atrial fibrillation (AF) following cardiac surgery. In a canine cardiac surgery model, we evaluated the impact of dietary ω3-PUFA on atrial electrophysiological properties, inflammatory markers, the atrial endothelin-1 (ET-1) system, and the expression and distribution of connexin 43.

Methods and results: Adult mongrel dogs received either normal chow (NC, n = 11) or chow supplemented with fish oil (FO, 0.6 g ω3-PUFA/kg/day, n = 9) for 3 weeks before surgery. A left thoracotomy was performed, and the left atrial appendage (LAA) was excised. Atrial pacing/recording wires were placed, and the pericardium/chest was closed. The atrial ratio of ω6/ω3 lipids decreased from 15-20 in NC to 2-3 in FO. FO treatment lowered pre-surgical and stabilized post-surgical arachidonate levels. Peak neutrophil to lymphocyte ratio was lower and decayed faster in FO-treated animals. Extensive inflammatory cell infiltration was present in NC atria, but was reduced in FO-treated dogs. FO-treated animals had lower post-surgical atrial expression of inducible nitric oxide synthase (iNOS) and reduced plasma ET-1. Expression of ET-1 and inositol trisphosphate receptor type-2 proteins in the LAA was also reduced. FO treatment prolonged post-operative atrial effective refractory period, slowed heart rate, and enhanced heart rate variability. Importantly, AF (>30 s) was inducible in four of six NC dogs, but no FO dogs.

Conclusion: Dietary FO attenuated AF inducibility following cardiac surgery by modulating autonomic tone and heart rate. FO also reduced atrial inflammation, iNOS, and ET-1 expression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrial Fibrillation / prevention & control*
  • C-Reactive Protein / analysis
  • Cardiac Surgical Procedures / adverse effects*
  • Connexin 43 / analysis
  • Connexin 43 / metabolism
  • Dogs
  • Endothelin-1 / analysis
  • Fatty Acids, Omega-3 / administration & dosage*
  • Female
  • Heart Rate
  • Inositol 1,4,5-Trisphosphate Receptors / analysis
  • Lipids / blood
  • Male
  • Nitric Oxide Synthase Type II / analysis
  • Peroxidase / analysis
  • Phosphorylation
  • Postoperative Complications / prevention & control*
  • Receptors, Endothelin / analysis

Substances

  • Connexin 43
  • Endothelin-1
  • Fatty Acids, Omega-3
  • Inositol 1,4,5-Trisphosphate Receptors
  • Lipids
  • Receptors, Endothelin
  • C-Reactive Protein
  • Peroxidase
  • Nitric Oxide Synthase Type II